There are nearly 1 billion people in the world suffering from a mental health disorder.
We need to make psychedelic therapy accessible, so more people can begin healing now.
Our platform supports three major stakeholders:
We give researchers access to unique real world data that can inform clinical trial design and commercialization strategies, and optimize trial outcomes.Learn more
We save providers time by automating screening, intake, preparation, and integration. Practice analytics inform greater health outcomes.Learn more
We offer those receiving psychedelic therapy the opportunity to feel safe, gain insight into their healing journey, and learn about their own process.Coming soon
Our work stems from our background in academic research with Johns Hopkins University through Unlimited Sciences. Following our involvement helping Denver become the first city to decriminalize psilocybin mushrooms, we have become deeply connected with psychedelic practitioners and researchers all over the world.About Us
Psychiatrist, Founder, Kuya Treatment Center
Director of Psychedelics Division, Neuroscape, UCSF